About this information

NICE guidelines provide advice on the care and support that should be offered to people who use health and care services.

This information explains the advice about Crohn's disease that is set out in NICE guideline CG152.

Information about treatment with infliximab and adalimumab was added in 2016. This information is in the section drug treatment for active Crohn's disease.

Does this information apply to me?

Yes, if you are an adult (18 years or older), child (11 years or younger) or young person (12 to 17 years) who has been diagnosed with Crohn's disease, or are a parent or carer of a person with Crohn's disease.

  • Information Standard